AF-React study: atrial fibrillation management strategies in clinical practice-retrospective longitudinal study from real-world data in Northern Portugal.
Susana Silva PintoAndreia Sofia Costa TeixeiraTeresa S HenriquesHugo MonteiroCarlos MartinsPublished in: BMJ open (2021)
The prevalence of AF is 3%. Here, we report evidence of both undertreatment and overtreatment. Although having an indication, a considerable proportion of patients (27.1%) are not anticoagulated, and among patients with AF without an indication to receive anticoagulation therapy, a considerable proportion (40.9%) are receiving anticoagulants. The AF-React study brings extremely relevant conclusions to Portugal and follows real-world studies in patients with AF in Europe, presenting some data not yet studied.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- clinical practice
- heart failure
- end stage renal disease
- ejection fraction
- percutaneous coronary intervention
- newly diagnosed
- electronic health record
- venous thromboembolism
- big data
- left ventricular
- machine learning
- bone marrow
- patient reported outcomes
- deep learning
- mesenchymal stem cells
- mitral valve
- cell therapy